Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
---|---|---|---|---|
Income Statement | - | |||
Total Revenue | - | - | - | - |
Gross Profit | - | - | - | - |
EBIT | - | - | - | - |
EBITDA | - | - | - | - |
Net Income Common Stockholders | - | - | - | - |
Balance Sheet | - | |||
Cash, Cash Equivalents and Short-Term Investments | $ 12.20M | $ 40.21M | $ 14.22M | $ 7.25M |
Total Assets | $ 165.61M | $ 53.46M | $ 26.04M | $ 13.35M |
Total Debt | $ 9.40M | $ 1.91M | $ 2.28M | $ 0.00 |
Net Debt | $ -2.81M | $ -38.31M | $ -11.94M | $ -7.25M |
Total Liabilities | $ 36.02M | $ 11.03M | $ 11.04M | $ 5.23M |
Stockholders Equity | $ 129.59M | $ 42.42M | $ 14.99M | $ 8.12M |
Cash Flow | - | |||
Free Cash Flow | - | - | - | - |
Operating Cash Flow | - | - | - | - |
Investing Cash Flow | - | - | - | - |
Financing Cash Flow | - | - | - | - |